NVAX
Price
$5.73
Change
+$0.27 (+4.95%)
Updated
Nov 28, 6:59 PM EST
90 days until earnings call
SANA
Price
$4.24
Change
-$0.00 (-0.00%)
Updated
Nov 28, 6:59 PM EST
106 days until earnings call
Ad is loading...

Compare predictions NVAX vs SANA

Header iconNVAX vs SANA Comparison
Open Charts NVAX vs SANABanner chart's image
Novavax
Price$5.73
Change+$0.27 (+4.95%)
Volume$3.71M
CapitalizationN/A
Sana Biotechnology
Price$4.24
Change-$0.00 (-0.00%)
Volume$368.3K
CapitalizationN/A
View a ticker or compare two or three
NVAX vs SANA Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
NVAX vs. SANA commentary
Nov 29, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVAX is a Hold and SANA is a StrongBuy.

COMPARISON
Comparison
Nov 29, 2023
Stock price -- (NVAX: $5.73 vs. SANA: $4.24)
Brand notoriety: NVAX: Notable vs. SANA: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NVAX: 87% vs. SANA: 48%
Market capitalization -- NVAX: $648.59M vs. SANA: $835.84M
NVAX [@Biotechnology] is valued at $648.59M. SANA’s [@Biotechnology] market capitalization is $835.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVAX’s FA Score shows that 0 FA rating(s) are green whileSANA’s FA Score has 0 green FA rating(s).

  • NVAX’s FA Score: 0 green, 5 red.
  • SANA’s FA Score: 0 green, 5 red.
According to our system of comparison, SANA is a better buy in the long-term than NVAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVAX’s TA Score shows that 4 TA indicator(s) are bullish while SANA’s TA Score has 5 bullish TA indicator(s).

  • NVAX’s TA Score: 4 bullish, 4 bearish.
  • SANA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SANA is a better buy in the short-term than NVAX.

Price Growth

NVAX (@Biotechnology) experienced а +7.10% price change this week, while SANA (@Biotechnology) price change was +5.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.02%. For the same industry, the average monthly price growth was +37.80%, and the average quarterly price growth was +9.00%.

Reported Earning Dates

NVAX is expected to report earnings on Feb 27, 2024.

SANA is expected to report earnings on Mar 14, 2024.

Industries' Descriptions

@Biotechnology (+5.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for NVAX with price predictions.
OPEN
A.I.dvisor published
a Summary for SANA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SANA($836M) has a higher market cap than NVAX($649M). SANA YTD gains are higher at: 7.342 vs. NVAX (-44.261). SANA has higher annual earnings (EBITDA): -266.82M vs. NVAX (-498.29M). NVAX has more cash in the bank: 651M vs. SANA (269M). SANA has less debt than NVAX: SANA (96.9M) vs NVAX (222M). NVAX has higher revenues than SANA: NVAX (974M) vs SANA (0).
NVAXSANANVAX / SANA
Capitalization649M836M78%
EBITDA-498.29M-266.82M187%
Gain YTD-44.2617.342-603%
P/E RatioN/AN/A-
Revenue974M0-
Total Cash651M269M242%
Total Debt222M96.9M229%
FUNDAMENTALS RATINGS
NVAX: Fundamental Ratings
NVAX
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
80
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NVAXSANA
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 21 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DWGAX10.000.04
+0.40%
American Funds Dvlpg Wld Gr&Inc A
HBLFX13.700.03
+0.22%
Hartford Balanced Income F
STNFX43.790.04
+0.09%
Allspring Large Cap Growth Inst
CHCGX46.25-0.03
-0.06%
Chesapeake Growth
SDVGX14.83-0.01
-0.07%
Sit Dividend Growth I

NVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVAX has been loosely correlated with CRSP. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if NVAX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVAX
1D Price
Change %
NVAX100%
+4.95%
CRSP - NVAX
47%
Loosely correlated
-1.33%
THRD - NVAX
41%
Loosely correlated
+0.26%
CHRS - NVAX
37%
Loosely correlated
+8.76%
SANA - NVAX
35%
Loosely correlated
N/A
AGEN - NVAX
35%
Loosely correlated
+6.63%
More

SANA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SANA has been loosely correlated with NTLA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if SANA jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SANA
1D Price
Change %
SANA100%
N/A
NTLA - SANA
62%
Loosely correlated
+0.33%
BEAM - SANA
61%
Loosely correlated
+2.09%
CRSP - SANA
60%
Loosely correlated
-1.33%
VCYT - SANA
56%
Loosely correlated
-2.24%
EDIT - SANA
55%
Loosely correlated
+0.80%
More